Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for lymphocytic bronchi(oli)tis after lung transplantation
2010-018724-16Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of azithromycin in large-airway lymphocytic bronchitis, Lymphocytic bronchiolitis (LB) and bronchial biopsy abnormality after lung transplantation, sponsored by KU Leuven. Primary endpoint: Histologic evolution of bronchial inflammation at 3 months. Started Apr 2010; status: completed.
02
Drugs
azithromycin
03
Conditions
large-airway lymphocytic bronchitisLymphocytic bronchiolitis (LB)bronchial biopsy abnormality after lung transplantation
Beyond the preview
Go deeper on 2010-018724-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018724-16.